Citations

Clear

1152 citation(s) found for "Todd, A".

Client Perceptions of the OQ‐45 Outcome Assessment With Practicum Counselors‐in‐Training: A Mixed‐Methods Analysis
Leibert, Todd W. , Vannest, Rebecca J. , Crockett, Stephanie A. , Powell, Richard N., Fonseca, Emrys

Mayo Clinic

Journal of Counseling & Development | July 17, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1002/jcad.70055 Get It

ABSTRACT Clinicians tend to overestimate their clients’ progress in treatment. A potential solution of adding formalized assessments into treatment has led to concerns about client paperwork burden. In this mixed‐method study, we explored adult clients’ reactions to one formal assessment, the Outcome Questionnaire‐45 (OQ‐45). We used purposeful sampling to select 17 clients at a university counseling training center who had either improved, showed little change, or who deteriorated according to OQ‐45. Using semi‐structured interviews and grounded theory, we identified two higher order categories, clinical benefits and threats to accuracy, and two axial categories, OQ‐45 likability and perceived accuracy. A crossover mixed analysis showed strong correlations between OQ‐45 outcomes, clinical benefits, and OQ‐45 likability. We proposed a conceptual model showing how client attitudes toward the OQ‐45 depended on how compatible outcomes were to clients’ perceived benefits received in counseling. Counseling implications and future research directions are discussed.
Hypothalamus as a conductor of the migraine prodrome: A narrative review
Root, Shane , Schwedt, Todd J. , Schwedt, Todd J

Mayo Clinic

Headache: The Journal of Head and Face Pain | July 1, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1111/head.70161 | PMID 42383290 Get It

Abstract Objectives/Background This narrative review summarizes evidence implicating a role for the hypothalamus in the prodrome phase of a migraine attack. Prodrome is the earliest phase of the migraine attack. Understanding the migraine prodrome could lead to a better description of how migraine attacks are initiated and identification of targets for acute and preventive migraine treatment. The hypothalamus has been implicated in migraine prodrome via (1) localization of common prodrome symptoms to the hypothalamus; (2) identification of neurotransmitters, peptides, and hormones important in migraine pathophysiology for which the hypothalamus influences their production or release; and (3) brain neuroimaging studies identifying changes in hypothalamic activity and functional connectivity during the prodrome and preheadache phases of the migraine attack. Methods For this narrative review, PubMed was searched for relevant English language articles using the terms “hypothalamus, prodrome,” “hypothalamus, premonitory,” “hypothalamus, migraine,” “migraine, prodrome,” and “migraine, premonitory.” The PubMed search was performed on October 29, 2025. Full articles were chosen for review based on their relevance to the three areas defined just above: symptom localization, neuropeptide/neurotransmitter release, and brain imaging. Results Those with migraine commonly, and often consistently, experience prodrome symptoms, including hypersensitivities to visual and auditory stimuli, neck pain, fatigue, sleep–wake disturbances, changes in appetite, mood changes, and alterations in thermoregulation perception. Many of these symptoms can be localized to functions of hypothalamic subregions and nuclei. Several neuropeptides, neurotransmitters, and hormones that contribute to prodrome and other migraine attack symptoms, including calcitonin gene‐related peptide, dopamine, orexins, and pituitary adenylate cyclase‐activating polypeptide, are either produced by the hypothalamus or their release is mediated by the hypothalamus. Functional neuroimaging studies of spontaneous and triggered migraine attacks have identified increased hypothalamic activity and altered hypothalamic functional connectivity before migraine headache onset, including during the prodrome. Conclusion There is compelling evidence that the hypothalamus plays a role in the migraine prodrome and likely in migraine attack initiation. This is supported by many migraine prodrome symptoms localizing to hypothalamic function and functional neuroimaging studies demonstrating increased activity and altered connectivity of the hypothalamus during the prodrome phase. Further evidence and research are required to understand the hypothalamus' contribution relative to other brain regions.
Preserving Relational Letter Writing in the Era of Artificial Intelligence
Rasmussen, Todd E.

Mayo Clinic

JAMA Surgery | June 24, 2026 | Volume: 161 | Issue: 8 | Pages: 759

10.1001/jamasurg.2026.2165 | PMID 42340712 Get It

This Viewpoint describes writing letters of recommendation in the era of artificial intelligence.
Financial Comparison of Single- vs 2-Stage Management of Bile Duct Stones
Jorge, Irving, Kandil, Omneya , Huschka, Todd, Joshi, Devendra, Ven Fong, Zhi, Jorge, Irving , Joshi, Devendra, Huschka, Todd , Fong, Zhi Ven , Borah, Bijan J.

Mayo Clinic

JAMA Surgery | June 24, 2026 | Volume: 161 | Issue: 8 | Pages: 846

10.1001/jamasurg.2026.2185 | PMID 42340701 Get It

This economic evaluation assesses the costs, reimbursements, and estimated net operating margin of single- and 2-stage strategies for managing bile duct stone clearance to compare the financial outcomes of both strategies.
Metabolomic Network Analysis Reveals Reorganization of Lipid and Steroid Programs Linked to Right Ventricular-Pulmonary Vascular Function in Pulmonary Hypertension
Clinton, Ivor, Coursen, Julie , Rosen, Darin , Suresh, Karthik , Balasubramanian, Aparna , Kolb, Todd M. , Damico, Rachel L. , Mathai, Stephen C. , Hsu, Steven , Mukherjee, Monica , Finet, J. Emanuel , Grünig, Gabriele , Rischard, Franz, Erzurum, Serpil C. , Beck, Gerald J. , Hill, Nicholas S. , Group, PVDOMICS Study, Clinton, Ivor W , Coursen, Julie C , Rosen, Darin T , Barnard, John , Hemnes, Anna , Leopold, Jane A , Horn, Evelyn M , Rosenzweig, Erika B , Frantz, Robert P , Erzurum, Serpil C , King, Wendy , Beck, Gerald J , Hill, Nicholas S , Hassoun, Paul M , Simpson, Catherine E , Mathai, Stephen C , Balasubramanian, Aparna , Mukherjee, Monica , Hsu, Steven , Barnard, John , Hemnes, Anna R. , Leopold, Jane A. , Horn, Evelyn M. , Rosenzweig, Erika B. , Rischard, Franz , Frantz, Robert P. , King, Wendy C. , Hassoun, Paul M. , Simpson, Catherine E. , Group, PVDOMICS Study

Mayo Clinic

No container title available | June 22, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.06.16.732773 | PMID 42395385 Get It

ABSTRACT Background Pulmonary arterial hypertension (PAH) is characterized by circulating metabolic alterations, but whether these reflect disease-specific metabolic programs or reorganization of normal metabolic architecture, and how they relate to right ventricular-pulmonary vascular function (RV-PV), remains unclear. We hypothesized that the PAH metabolome is organized into biologically coherent, co-regulated metabolic modules whose relationships to RV-PV function would provide insight into known and novel metabolic pathways. Methods We applied weighted gene co-expression network analysis (WGCNA) to untargeted metabolomic data from 412 PAH patients enrolled in the multicenter PVDOMICS study. Module preservation analysis was performed in 85 healthy controls, with external replication in an independent single-center pulmonary hypertension cohort of 89 patients. Results WGCNA identified 16 distinct metabolic modules organized around biologically coherent programs. A coherent fatty acid axis, spanning substrate pools, β-oxidation intermediates, and conjugated fatty acid disposal products, formed a central organizing structure, with downstream fatty acid oxidation modules strongly associated with adverse hemodynamics and worse RV-pulmonary artery (PA) coupling. Acylcholine-enriched and 5α-reduced androgen metabolite modules were associated with favorable hemodynamic indices. Module architecture was largely preserved in healthy controls, with subtle disease-associated modular reorganization, rather than emergence of novel modules, observed in PAH. Core modules were recovered in the replication cohort with conserved hub metabolites. Conclusions These findings establish a systems-level framework demonstrating that PAH involves structured intensification and reorganization of interconnected metabolic programs associated with favorable and adverse RV-PV phenotypes. This work provides new insight into the metabolic architecture underlying PAH and identifies coordinated metabolic pathways linked to pulmonary vascular and right ventricular function.
Development of a Core Outcome Domain Set for Facial Aging
Dirr, McKenzie A. , Ahmed, Areeba, Schlessinger, Daniel I., Lazaro-Camp, Vanessa, Smith, SJ, Gullapalli, Thanvi, Dragovic, Doroteja, Chang, Joycie, Zhang, Elizabeth, Alam, Murad, Group, Facial Aging Core Outcome Domain Set Study, Anvery, Noor , Kang, Bianca Y. , Wong, Clarissa, Iyengar, Sanjana, Yanes, Arianna F. , Cotseones, Jill, Ashchyan, Hovik J. , Patel, P. M., Sheikh, Umar A., Franklin, Matthew , Hanna, Courtney, Chiren, Sarah G., Schmitt, J, Furlan, Karina C., Alexiades, Macrene, Alhusayen, Raed, Alster, Tina S. , Beer, Kenneth, Bertucci, Vince , Bloom, Jason D. , Briceño, César A., Bucay, Vivian, Butterwick, Kimberly J., Hugues, Cartier, Casabona, Gabriela, Connolly, Karen , Cox, Sue Ellen , Darmanescu, Monica, Boulle, Koenraad De , Desai, Shraddha, Donofrio, Lisa, Dover, Jeffrey S., Draelos, Zoe, Eisen, Daniel B. , El-Domyati, Moetaz, El-Garem, Yehia, Fischer, John, Fitzgerald, Rebecca, GALADARI, Hassan, Gladstone, Hayes B., Goldman, Mitchel P., Goodman, Greg J., Hanke, C. William , Humphrey, Shannon, Ibrahim, Sherrif F., Jagdeo, Jared, Karen, Julie, Kauvar, Arielle, Ag, Kibbi, KIM, JENNY, Lacerda, D T D, Lask, G, Lopez, Grace M., Lupo, Mary P. , Mariwalla, Kavita , Matarasso, Seth, Mekokishvili, L, Narins, Rhoda S., Ogilvie, P, Orringer, Jeffrey S. , Osaki, Tammy H. , Ozog, David, Pacheco, Theresa, Polder, Kristel, Rossi, Anthony M, Sadick, Neil, Saedi, Nazanin, Schlessinger, Joel, Sharad, Jaishree , Shenoy, SuchitraM, Sinclair, Rd, Solish, Nowell, Piansay‐Soriano, Miriam Emily , Sulyman, Omotara , Szeimies, Rolf‐Markus , Tanzi, Elizabeth L., Taub, Amy Forman , Taylor, Mark B., Thomas, J. Regan, Torezan, Luis, Tosti, Antonella, Touma, Dany, Almeida, Ada Regina Trindade de , Vedamurthy, Maya , Viana, Giovanni, Waldman, Abigail, Weinkle, Susan, Weiss, Robert, Poon, Emily, Cartee, Todd V. , Sobanko, Joseph F. , Eisen, Daniel B. , Ahmed, Areeba , Schlessinger, Daniel Isaac , Lazaro-Camp, Vanessa J, Christensen, Rachel E. , Ibrahim, Sarah A. , Cotseones, J.K., Umar, Sheikh Ahmad , Furlan, Karina Colossi , Alexiades, Macrene , Alhusayen, Raed , Beer, Kenneth Robert, Briceño, César Augusto , Bucay, Vivian , Casabona, Gabriela , Cotofana, Sebastian , Desai, Shraddha , Dover, Jeffrey S. , Draelos, Zoe Diana , Eisen, Daniel B., El-Domyati, Moetaz M. , El-Garem, Yehia, Fitzgerald, Rebecca, Friedmann, Daniel P. , Galadari, Hassan , Gladstone, Hayes B., Goldman, Mitchel P. , Goodman, Greg , Green, Jeremy B. , Halachmi, Shlomit , Humphrey, Shannon , Jagdeo, Jared R. , Jiang, Shang I. Brian , Kauvar, Arielle N.B. , Kibbi, Abdul‐Ghani , Kim, John V. S., LASK, GARY P., Matarasso, Seth L., Narins, Rhoda S., Ogilvie, Patricia , Osaki, Tammy H. , Pacheco, Theresa , Polder, Kristel D., Saedi, Nazanin, Shenoy, Manjunath , Sinclair, Rod, Solish, Nowell , Torezan, Luís , Tosti, Antonellá , Waldman, Abigail , Weiss, Robert, Maher, Ian A. , Kirkham, Jamie J

Mayo Clinic

JAMA Dermatology | June 17, 2026 | Volume: 162 | Issue: 8 | Pages: 829

10.1001/jamadermatol.2026.1697 | PMID 42307924 Get It

Importance Currently, there are no standardized outcome domains or measures in clinical trials for facial aging. Heterogeneity in outcome domains and measurement instruments across clinical trials creates difficulty in directly comparing interventions, determining superior therapies, and developing high-quality meta-analyses. Objective To develop a core outcome set (COS) of essential domains to be reported in clinical trials evaluating the efficacy of interventions for facial aging. Evidence Review PubMed/Medline, Embase, Cochrane Central Register of Controlled Trials, and CINAHL were searched from September 2005 to September 2015. An updated search of the same databases was performed from September 2015 to February 2026. Studies were included if (1) they were randomized clinical trial or controlled clinical trial in design, (2) they assessed the efficacy or safety of an intervention for facial aging, (3) they were published in English, and (4) they involved human participants. Complementary sources, including patient interviews, were used to capture further relevant outcomes. Two rounds of Delphi surveys, followed by consensus meetings, were used to identify outcome domains considered most important by both patient and physician stakeholders. Findings The final COS consists of 6 outcome domains: (1) overall convenience of treatment; (2) time to return to normal work and social activity; (3) overall assessment of focused area of treatment (at the point in time when treatment is expected to provide peak benefit); (4) duration of treatment effect; (5) severity of persistent local or systemic adverse events, including pigmentary change, skin texture change, delayed healing, scarring, and serious adverse events; and (6) patient satisfaction with treatment. Conclusions and Relevance The 6 outcome domains identified through a Delphi consensus are recommended for reporting in future facial aging trials to ensure that outcomes that matter most to patients and clinicians are measured and that results are comparable across interventions.
Sexually dimorphic mediation of experimental post-traumatic headache by orexin receptor signaling
Vizin, Robson Cristiano Lillo , Anderson, Trent, Porreca, Frank , Anderson, Trent , Lee, Grace J. , Lillo Vizin, Robson C , Kopruszinski, Caroline , Porreca, Frank , Kopruszinski, Caroline Machado , Lee, Grace , Moutal, Aubin , Dodick, David W. , Schwedt, Todd J. , Navratilova, Edita

Mayo Clinic

Pain | June 16, 2026 | Volume: 167 | Issue: 9 | Pages: 2156-2170

10.1097/j.pain.0000000000004035 | PMID 42302125 Get It

Abstract Mild traumatic brain injury (mTBI) commonly induces transient acute (APTH) or persistent (PPTH) post-traumatic headache (PTH) that often resembles migraine. As orexin B sensitizes male but not female murine, nonhuman primate, and human dorsal root ganglion neurons and supradural orexin B/orexin receptor 2 (OX2R) signaling elicits migraine-like pain in naïve male, but not female, mice we explored possible sexually dimorphic contributions of orexin B/OX2R to PTH. In mice of both sexes, mTBI-induced transient cephalic allodynia, a surrogate measure of APTH. After APTH resolution, allodynia was reinstated by exposure to normally innocuous stress or by inhalational delivery of a subthreshold concentration of umbellulone, a TRPA1 agonist, suggesting the expression of PPTH. In contrast to these nonselective stimuli, subthreshold supradural orexin B induced PPTH only in male mTBI mice. Intranasal delivery of a CRISPR/Cas9 plasmid to edit trigeminal OX2R expression prevented APTH and development of PPTH selectively in male mTBI mice. Daily oral suvorexant, a dual orexin receptor antagonist (DORA), beginning immediately after mTBI, prevented APTH as well as PPTH. Critically, starting suvorexant treatment after resolution of APTH also prevented stress- or umbellulone-induced PPTH. EEG/EMG-defined sleep architecture or immobility-defined sleep was not disrupted in this mTBI model suggesting that suvorexant benefits are unlikely related to sleep modulation. Our findings reveal a male-specific mechanism of PTH maintained by orexin B/OX2R signaling and suggest that approved DORAs may be beneficial in treating APTH and preventing transition to PPTH in men. Importantly, DORAs may also be effective in men with established PPTH.
Brain Structural and Functional Alterations in Regions of Pain-processing in Individuals with Rheumatoid Arthritis (P5-2.002)
Chong, Catherine, Musa, Juna , Crowson, C. S., Irani, Anushka, Schwedt, Todd, Welker, Kirk, Davis, John, Schwedt, Todd J. , Davis, John M.

Mayo Clinic

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000216313 Get It

Headache Specialists versus Artificial Intelligence for Clinical Literature Summarization: A Critical Evaluation and Comparison (P9-15.009)
Lozano, Alejandro, Yang, Ping‐Hao , Robertson, Carrie, Stern, Jennifer, Purdy, Allan, Zhang, Pengfei, Orlova, Yulia, Fermo, Olga, Hranilovich, Jennifer, Schwedt, Todd, Yeung-Levy, Serena, Chiang, Chia‐Chun , Ihara, Keiko , Yuan, Hsiangkuo , Orlova, Yulia , Fermo, Olga , Hranilovich, Jennifer A. , Cohen, Fred , Schwedt, Todd J.

Mayo Clinic

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000215849 Get It